American Pharmacists Associationhttp://www.pharmacist.com/Publications/Pharmacy-Today/October-2025/rss/3814RSS document<![CDATA[Trending Topics]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-32Sat, 06 Sep 2025 16:00:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/trending-topics-32<![CDATA[Gray areas persist in managing obesity and heart failure]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/gray-areas-persist-in-managing-obesity-and-heart-failureWed, 06 Aug 2025 16:00:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/gray-areas-persist-in-managing-obesity-and-heart-failure<![CDATA[No clear advantage for hospital-wide switch to lactated Ringer’s, finds study]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/no-clear-advantage-for-hospital-wide-switch-to-lactated-ringers-finds-studySat, 06 Sep 2025 16:00:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/no-clear-advantage-for-hospital-wide-switch-to-lactated-ringers-finds-study<![CDATA[Apixaban may outperform rivaroxaban and warfarin for VTE treatment]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/apixaban-may-outperform-rivaroxaban-and-warfarin-for-vte-treatmentSat, 06 Sep 2025 16:00:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/apixaban-may-outperform-rivaroxaban-and-warfarin-for-vte-treatment<![CDATA[Post-discharge ondansetron reduces severity of pediatric gastroenteritis, trial shows]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/post-discharge-ondansetron-reduces-severity-of-pediatric-gastroenteritis-trial-showsSat, 06 Sep 2025 16:00:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/post-discharge-ondansetron-reduces-severity-of-pediatric-gastroenteritis-trial-shows